Skip to main content
Recall Canary
Xanax XR Alprazolam 3 mg Tablets
← Back to all recalls
DRUG RECALLMODERATE

Xanax XR Alprazolam 3 mg Tablets

Viatris is recalling Xanax XR 3 mg tablets (NDC 58151-506-91) due to failed dissolution specifications.

What to do

Do not use this medication. Contact your pharmacy or healthcare provider immediately for a replacement or alternative treatment. Return the recalled product to your pharmacy.

Recalled
Listed
Updated
Recall No.
D-0444-2026
Agency
FDA
Firm
Viatris, Inc.
Recall ID
98613
Status
ONGOING

Why it was recalled

Viatris Specialty LLC is recalling Xanax XR (alprazolam) extended-release tablets, 3 mg, in 60-tablet bottles (NDC 58151-506-91) distributed nationwide due to failed dissolution specifications. Affected tablets may not dissolve properly, potentially affecting drug bioavailability and therapeutic efficacy.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Xanax XR, alprazolam, extended-release tablets

Strength
3 mg
NDC / UPC
NDC 58151-506-91

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification